Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain

BACKGROUND: Sublingual (s.l.) administration of soluble protein antigens, inactivated viruses, or virus-like particles has been shown to induce broad immune responses in mucosal and extra-mucosal tissues. Recombinant replication-defective adenovirus vectors (rADVs) infect mucosa surface and therefor...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shim, Byoung-Shik, Stadler, Konrad, Nguyen, Huan Huu, Yun, Cheol-Heui, Kim, Dong Wook, Chang, Jun, Czerkinsky, Cecil, Song, Man Ki
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3489719/
https://ncbi.nlm.nih.gov/pubmed/22995185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1743-422X-9-215
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares